Targeting vascular endothelial growth factor (VEGF) pathway in iodine-refractory differentiated thyroid carcinoma (DTC): From bench to bedside

This publication has 49 references indexed in Scilit:

• Targeting vascular endothelial growth factor (VEGF) pathway in gastric cancer: Preclinical and clinical aspects
  Critical Reviews in Oncology/Hematology, 2015
• Molecular pathogenesis and mechanisms of thyroid cancer
  Nature Reviews Cancer, 2013
• RET TKI: Potential Role in Thyroid Cancers
  Current Oncology Reports, 2012
• Multikinase inhibitors: a new option for the treatment of thyroid cancer
  Nature Reviews Endocrinology, 2011
• Thyroid Cancer Incidence Patterns in the United States by Histologic Type, 1992–2006
  Thyroid®, 2011
• Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
  Annals of Oncology, 2010
• Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
  Thyroid®, 2009
• Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005
  Cancer, 2009
• European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
  European Journal of Endocrinology, 2006
• Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
  Journal of Clinical Oncology, 2005